EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis

Jihye Hyun, Jooyoung Lee, Tuan Thanh Nguyen, Se Young Choi

Prostate International · 2025-09 · 13 (3) · 148-154

DOI: 10.1016/j.prnil.2025.01.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prostate International, 2025-09. Verfasst von Jihye Hyun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Statistics, Chung-Ang University, Seoul, Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Different treatments for prostate cancer (PC) could affect a patient's risk of developing second primary cancers (SPCs). We assessed the incidence of SPC and overall survival (OS) after SPC diagnosis in patients with PC who underwent radical prostatectomy (RP) or radiation therapy (RT) as primary treatment.

Methods

Using the National Health Insurance Service database in South Korea, all male patients with PC between 2002 and 2018 were corrected for selection bias between the RT and RP groups by inverse probability of treatment weighting. The primary outcome was the incidence of SPC, and secondary outcome was OS after SPC diagnosis; cumulative incidence functions for competing risks of each SPC type were evaluated between the RP and RT groups. Cox regression analysis evaluated OS after SPC.

Results

Among 26,254 patients with PC, 20.3% and 79.7% were treated with RT and RP, respectively. Patients with PC had a 7% lower risk of all SPCs than the general male population [standardized incidence ratio (SIR) = 0.93]. Bladder (SIR = 1.65) and thyroid (SIR = 2.75) cancers were more common in both treatment groups. At 10-year follow-up, patients who underwent RP were less likely to have colon cancer than those who underwent RT [risk difference (%) = -0.9]. The former had a lower risk of death following lung (aHRs: 0.70; P = 0.010) and colon (aHRs: 0.53; P = 0.001) SPCs and a higher risk of death following esophageal SPC (aHRs: 6.9; P = 0.008).

Conclusions

SPC incidence and OS after SPC diagnosis may be influenced by the initial PC treatment. The choice of primary treatment for PC should guide the follow-up care and subsequent treatment strategies for SPCs.

Schlagwörter

Stichwörter der Autor:innen

Prostatic neoplasmsRepublic of KoreaSecond primary neoplasmsSecondary primary malignancies

Autor:innen und Institutionen

  • Department of Applied Statistics, Chung-Ang University, Seoul, Korea.
  • Department of Urology, Cho Ray Hospital, University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam.
  • Department of Urology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Hyun, J., Lee, J., Nguyen, T. T., & Choi, S. Y. (2025). Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis. Prostate International, 13(3), 148-154. https://doi.org/10.1016/j.prnil.2025.01.004

Vancouver

Hyun J, Lee J, Nguyen TT, Choi SY. Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis. Prostate International. 2025;13(3):148-154. doi:10.1016/j.prnil.2025.01.004

BibTeX
@article{Hyun2025,
  author = {Hyun, Jihye and Lee, Jooyoung and Nguyen, Tuan Thanh and Choi, Se Young},
  title = {Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis},
  journal = {Prostate International},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {148--154},
  doi = {10.1016/j.prnil.2025.01.004}
}
Kostenlos starten →